Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | AZN | AMGN | GILD | VRTX |
| Company | Royalty Pharma Plc Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 46.37 | 191.25 | 369.50 | 145.00 | 480.44 |
| High | 46.49 | 191.25 | 369.50 | 145.00 | 480.44 |
| Low | 45.63 | 191.25 | 369.50 | 145.00 | 480.44 |
| Latest | 45.87 | 191.25 | 369.50 | 145.00 | 480.44 |
| Change | -0.82 | -1.25 | +1.71 | -0.21 | +2.31 |
| % Change | -1.76% | -0.65% | +0.46% | -0.14% | +0.48% |
| Volume | 3,834,800 | 12,935 | 3,548 | 1,994 | 361 |
| 20-Day Average Volume | 3,512,530 | 1,941,892 | 2,441,302 | 6,379,440 | 1,427,083 |
| Previous Close | 46.69 | 192.50 | 367.79 | 145.21 | 478.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 45.82 | 201.60 | 376.65 | 148.47 | 479.02 |
| 20-Day Raw Stochastic | 47.77% | 8.13% | 27.11% | 15.73% | 52.00% |
| 20-Day Relative Strength | 59.73 | 45.12 | 52.46 | 52.06 | 52.43 |
| Weighted Alpha | +44.74 | +27.67 | +25.44 | +36.32 | +2.97 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.42% since 03/05/26 | -1.53% since 03/06/26 | -0.01% since 03/06/26 | +0.74% since 03/06/26 | +5.20% since 03/06/26 |
| Low | 44.94 on 03/06/26 | 189.35 on 03/09/26 | 366.53 on 03/09/26 | 143.49 on 03/09/26 | 450.78 on 03/09/26 |
| High | 46.82 on 03/11/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | +2.39% since 02/12/26 | -6.96% since 02/13/26 | +0.08% since 02/13/26 | -6.44% since 02/13/26 | -2.24% since 02/13/26 |
| Low | 44.67 on 02/20/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 47.86 on 03/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | +19.48% since 12/12/25 | +6.45% since 12/12/25 | +16.29% since 12/12/25 | +20.43% since 12/12/25 | +6.28% since 12/12/25 |
| Low | 37.83 on 12/16/25 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 47.86 on 03/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +26.16% since 09/12/25 | +20.19% since 09/12/25 | +33.69% since 09/12/25 | +26.58% since 09/12/25 | +21.78% since 09/12/25 |
| Low | 34.63 on 09/26/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 47.86 on 03/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,460,430 | 298,549,792 | 198,263,824 | 180,266,752 | 121,461,280 |
| Shares Outstanding, K | 576,857 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 2,378,190,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 770,950,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 621,990,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | 214,210,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.40 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.17 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | 0.235 on 02/20/26 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | 02/20/26 | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 9.67 | 21.10 | 17.28 | 17.91 | 29.99 |